Accretion Nutraveda Limited (BOM:544694)
India · Delayed Price · Currency is INR 163.65
+7.75 (4.97%)
At close: Feb 12, 2026
Accretion Nutraveda Market Cap
Accretion Nutraveda has a market cap or net worth of 1.22 billion as of February 13, 2026.
Market Cap
1.22B
Enterprise Value
1.26B
Revenue
160.49M
Ranking
n/a
PE Ratio
23.37
Stock Price
163.65
Market Cap Chart
Since February 4, 2026, Accretion Nutraveda's market cap has decreased from 1.38B to 1.22B, a decrease of -12.13%. That is a compound annual growth rate of -99.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.22B | 2.66% |
| Feb 12, 2026 | 1.18B | 4.97% |
| Feb 11, 2026 | 1.13B | -5.00% |
| Feb 10, 2026 | 1.19B | -3.47% |
| Feb 9, 2026 | 1.23B | -3.79% |
| Feb 6, 2026 | 1.28B | -5.00% |
| Feb 5, 2026 | 1.35B | -2.72% |
| Feb 4, 2026 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bilcare | 1.57B |
| Pharmaids Pharmaceuticals | 1.38B |
| Sotac Pharmaceuticals | 1.37B |
| Parnax Lab | 1.36B |
| Lactose (India) | 1.29B |
| Bal Pharma | 1.17B |
| Concord Drugs | 1.06B |
| Mercury Laboratories | 966.18M |